113 related articles for article (PubMed ID: 10635069)
21. Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.
Yeung MW; Young J; Moodie E; Rollet-Kurhajec KC; Schwartzman K; Greenaway C; Cooper C; Cox J; Gill J; Hull M; Walmsley S; Klein MB
HIV Clin Trials; 2015; 16(3):100-10. PubMed ID: 25972048
[TBL] [Abstract][Full Text] [Related]
22. Progression of hepatitis C in the haemophiliac population in Ireland, after 30 years of infection in the pre-DAA treatment era.
Murphy N; O'Mahony B; Flanagan P; Noone D; White B; Bergin C; Norris S; Thornton L;
Haemophilia; 2017 Sep; 23(5):712-720. PubMed ID: 28752601
[TBL] [Abstract][Full Text] [Related]
23. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
van der Helm J; Geskus R; Sabin C; Meyer L; Del Amo J; Chêne G; Dorrucci M; Muga R; Porter K; Prins M;
Gastroenterology; 2013 Apr; 144(4):751-760.e2. PubMed ID: 23266560
[TBL] [Abstract][Full Text] [Related]
24. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
Klein MB; Rollet KC; Saeed S; Cox J; Potter M; Cohen J; Conway B; Cooper C; Côté P; Gill J; Haase D; Haider S; Hull M; Moodie E; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S;
HIV Med; 2013 Jan; 14(1):10-20. PubMed ID: 22639840
[TBL] [Abstract][Full Text] [Related]
25. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
[TBL] [Abstract][Full Text] [Related]
26. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
27. [ANTIRETROVIRAL THERAPY AND THE RISK OF LIVER FIBROSIS PROGRESSION IN HIV/HCV COINFECTED PATIENTS].
Arystanbekova M; Balmasova I; Malova E; Sepiashvili R
Georgian Med News; 2017 May; (266):58-63. PubMed ID: 28628016
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis C virus infection in internal medicine and infectious diseases departments in France. Preliminary results of a national epidemiological survey].
Cacoub P; Raguin G; Veyssier P; Piette JC; Micoud M; Godeau P
Presse Med; 1996 Mar 2-9; 25(8):349-52. PubMed ID: 8685181
[TBL] [Abstract][Full Text] [Related]
29. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
Crespo M; Navarro J; Moreno S; Sanz J; Márquez M; Zamora J; Ocampo A; Iribaren JA; Rivero A; Llibre JM
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):493-498. PubMed ID: 27061975
[TBL] [Abstract][Full Text] [Related]
30. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.
Merchante N; Girón-González JA; González-Serrano M; Torre-Cisneros J; García-García JA; Arizcorreta A; Ruiz-Morales J; Cano-Lliteras P; Lozano F; Martínez-Sierra C; Macías J; Pineda JA;
AIDS; 2006 Jan; 20(1):49-57. PubMed ID: 16327319
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
[TBL] [Abstract][Full Text] [Related]
32. INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.
Abutidze A; Bolokadze N; Chkhartishvili N; Sharvadze L; Tsertsvadze T
Georgian Med News; 2016 Mar; (252):10-5. PubMed ID: 27119828
[TBL] [Abstract][Full Text] [Related]
33. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues.
Poles MA; Dieterich DT
Clin Infect Dis; 2000 Jul; 31(1):154-61. PubMed ID: 10913414
[TBL] [Abstract][Full Text] [Related]
35. HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).
Santos ME; Protopopescu C; Sogni P; Yaya I; Piroth L; Bailly F; Marcellin F; Esterle L; Wittkop L; Rosenthal E; Morlat P; Roux P; de Araujo WN; Salmon-Ceron D; Carrieri MP;
AIDS Behav; 2020 Apr; 24(4):1069-1084. PubMed ID: 31286317
[TBL] [Abstract][Full Text] [Related]
36. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.
Carrieri MP; Protopopescu C; Marcellin F; Rosellini S; Wittkop L; Esterle L; Zucman D; Raffi F; Rosenthal E; Poizot-Martin I; Salmon-Ceron D; Dabis F; Spire B;
J Hepatol; 2017 Dec; 67(6):1157-1167. PubMed ID: 28942916
[TBL] [Abstract][Full Text] [Related]
38. HIV/hepatitis C virus-coinfected patients and cirrhosis: how to diagnose it and what to do next?
Martel-Laferrière V; Wong M; Dieterich DT
Clin Infect Dis; 2014 Mar; 58(6):840-7. PubMed ID: 24178247
[TBL] [Abstract][Full Text] [Related]
39. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.
Merchante N; Merino E; López-Aldeguer J; Jover F; Delgado-Fernández M; Galindo MJ; Ortega E; Rivero A; Mínguez C; Romero-Palacios A; Padilla S; Márquez-Solero M; Amador C; Ríos-Villegas MJ; Téllez F; Portilla J; Pineda JA
Clin Infect Dis; 2013 Jan; 56(1):143-50. PubMed ID: 22955438
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
